Nia Therapeutics is a team of visionary scientists, engineers and medical device experts dedicated to improving human memory using safe, secure neurotechnology.
Dr. Rizzuto developed Nia's core technology at the University of Pennsylvania as part of the DARPA Restoring Active Memory Project. He completed his doctorate in the neuroscience of human memory at Brandeis University, his postdoctoral training in brain-machine interfaces at Caltech.
Chief Software Architect
Daniel is an expert in developing secure, scalable, high-volume software systems. Before Nia, he worked at MIT Lincoln Lab developing cybersecurity technologies, where he won the R&D 100 award. He previously co-founded two software companies, both acquired.
Founder & Chairman of the Scientific Advisory Board
Mike is the Edmund and Louise Kahn Term Professor of Psychology at the University of Pennsylvania and the co-inventor of Nia’s core technology. Mike received the Troland Award and the Warren Medal for his discoveries in human memory and neuroscience.
Principal Software Developer
Chris is a full-stack software engineer with over 20 years of experience involving user interfaces, communication, databases, security, operations, and regulatory compliance. Chris was previously the director of technology at MD Connect.
Vice President of Quality and Regulatory Affairs
Marcella has a track record of overseeing healthcare quality and compliance initiatives. She was previously Director of Quality and Compliance at HDAI and Happify Health, and completed her bachelor's degree in computer engineering at Vanderbilt University.
Implantable Systems Engineer
Sr. Embedded Software Engineer
Josh Kahn is an experienced embedded software engineer who previously worked in the robotics and energy storage industries. He received his bachelor's degree in mechanical engineering from the Technion, the Israel Institute of Technology.
Professor, Dept. of Neurosurgery at Emory University
Royal Academy Chair in Emerging Technology at Oxford University
Professor of Neurology and Director of TBI Clinical Research, University of Pennsylvania
Associate Professor of Neurology at University of Pennsylvania
Executive Chairman at The Alfred Mann Foundation